Johnston, S R, Kilburn, L S, Ellis, P, Dodwell, D, Cameron, D, Hayward, L, Im, Y, Braybrooke, J P, Brunt, A M, Cheung, K, Jyothirmayi, R, Robinson, A, Wardley, A M, Wheatley, D, Howell, A, Coombes, G, Sergenson, N, Sin, H, Folkerd, E, Dowsett, M & Bliss, J M 2013, ' Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial ', The Lancet Oncology, vol. 14, no. 10, pp. 989-998 . https://doi.org/10.1016/S1470-2045(13)70322-X